Rethinking Mitomycin C Tips from glaucoma and refractive surgeons on ways to get the most out of this powerful drug while minimizing complications. (cont.)
Cornea Demystifying NSAIDs As bromfenac (Xibrom), a new topical nonsteroidal anti-inflammatory drug, nears FDA approval, ophthalmologists are still sorting out topical NSAIDs’ indications and risk-benefit profiles. (cont.)
Refractive Treating LASIK-Induced Aberrations A decade of success in refractive surgery for myopia has produced an inevitable outcome: exceedingly high expectations. Indeed, 20/20 is no longer good enough.(cont.)
